Mammalian cells for producing adeno-associated viruses
A mammalian and adenovirus technology, applied in the direction of viruses, viral peptides, microorganisms, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0176] Example 1: CHOK1SV GS-KO co-infected with adenovirus 5 virus TM Transient AAV production in
[0177] To determine the CHOK1SV GS-KO TM (Lonza, Slough, UK) Can the cells biologically produce and assemble the rAAV carrier protein, the CHOK1SV GS-KO TM Cells were transfected with two plasmids: pRC2-mi342 (6234, Clontech) and pAAV-GFP (AAV-400, Cell Biolabs) control vector (Catalogue Number: AAV-400 Cell Biolabs, San Diego, USA)( Image 6 ), in wt Ad5 virus (catalog number: VR-1516 TM , American Type Culture Collection, Manassas, USA). Under natural conditions, CHOK1SV GS-KO TM Cells do not accept adenovirus due to lack of viral receptors, but in the presence of cationic transfection reagents (Lipofectamine or PEI), negatively charged adenovirus 5 is able to enter CHOK1SV GS-KO TM cells, thereby providing all auxiliary elements. This concept was used to design the evaluation experiment, where CHOK1SVGS-KO TM Cells provided all elements (Rep-Cap and GOI by transfec...
Embodiment 2
[0178] Example 2: In the absence of viral co-infection, CHOK1SV GS-KO TM Transient rAAV production in
[0179] To determine that in the absence of wt Ad5 virus, CHOK1SV GS-KO TM Whether cells can produce rAAV, cells were engineered to express Ad5E1A and E1B using a method similar to Howe et al. (2005). A plasmid construct expressing E1A under the control of the TET-on promoter (pMF30, figure 2 ), expressing E1B under the control of a constitutive human CMV promoter (pMF23, image 3 ), and the Ad5 E1A-E1B open reading frame (pXC17.4_17AV5PerProKZ, Figure 4 ). CHOK1SV GS-KO was established by transfecting with pMF30 and selecting for cells able to survive in glutamine-free medium supplemented with 50 μM L-MSX TM Derived library ( Figure 5 A). CHOK1SV GS-KO was then transfected with pMF23 TM E1A, and select cells that can survive in glutamine-free medium supplemented with 50 μM L-MSX and 10 μg / mL puromycin ( Figure 5 A). The water control was contaminated in all gen...
Embodiment 3
[0180] Example 3: In the absence of viral co-infection, CHOK1SV GS-KO TM and permanent rAAV generation in HEK293.
[0181] Integrate landing pad suitable for subsequent RMCE to CHOK1SV GS-KO TM and HEK293 genomes, as from recombinant CHOK1SV TM Loci identified in cell lines (Fer1L4, NL1, 2, 3, 4, 5 and 6 (see eg WO2013190032A1 and EP2711428A1)). A schematic diagram of the arrangement of components within these landing pads is given in Figure 7 A, B and C are shown. The location of the Frt site between the SV40E promoter and the selectable marker allows it to be used in subsequent RMCE. Use of incompatible Frt sites (A, B, C, D, E, and F) and different reporter / selection markers ensures that the sites are independently addressable. Figure 8 displayed in 1 ( Figure 8 A), 2 ( Figure 8 B) and 3 ( Figure 8 C) Various permutations of AAV, Ad5 and GOI genes after RMCE in locus CHO- and HEK293-derived SSI cell lines.
[0182]To generate the HEK293 SSI host, a BLAT search...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



